These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 15753413

  • 1. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis.
    Roed HG, Langkilde A, Sellebjerg F, Lauritzen M, Bang P, Mørup A, Frederiksen JL.
    Neurology; 2005 Mar 08; 64(5):804-10. PubMed ID: 15753413
    [Abstract] [Full Text] [Related]

  • 2. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, Sørensen PS, Maas-Enriquez M, Sommerauer B, Hanna K, PRIVIG Study Group, UBC MS/MRI Research Group.
    Neurology; 2008 Jul 22; 71(4):265-71. PubMed ID: 18645164
    [Abstract] [Full Text] [Related]

  • 3. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
    Achiron A, Kishner I, Sarova-Pinhas I, Raz H, Faibel M, Stern Y, Lavie M, Gurevich M, Dolev M, Magalashvili D, Barak Y.
    Arch Neurol; 2004 Oct 22; 61(10):1515-20. PubMed ID: 15477504
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
    Kishiyama JL, Valacer D, Cunningham-Rundles C, Sperber K, Richmond GW, Abramson S, Glovsky M, Stiehm R, Stocks J, Rosenberg L, Shames RS, Corn B, Shearer WT, Bacot B, DiMaio M, Tonetta S, Adelman DC.
    Clin Immunol; 1999 May 22; 91(2):126-33. PubMed ID: 10227804
    [Abstract] [Full Text] [Related]

  • 5. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
    Beck RW, Cleary PA, Anderson MM, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR.
    N Engl J Med; 1992 Feb 27; 326(9):581-8. PubMed ID: 1734247
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
    Sühs KW, Hein K, Sättler MB, Görlitz A, Ciupka C, Scholz K, Käsmann-Kellner B, Papanagiotou P, Schäffler N, Restemeyer C, Bittersohl D, Hassenstein A, Seitz B, Reith W, Fassbender K, Hilgers R, Heesen C, Bähr M, Diem R.
    Ann Neurol; 2012 Aug 27; 72(2):199-210. PubMed ID: 22926853
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of neuroprotective qualities of brimonidine during LASIK.
    McCarty TM, Hardten DR, Anderson NJ, Rosheim K, Samuelson TW.
    Ophthalmology; 2003 Aug 27; 110(8):1615-25. PubMed ID: 12917182
    [Abstract] [Full Text] [Related]

  • 8. Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.
    Tsakiri A, Kallenbach K, Fuglø D, Wanscher B, Larsson H, Frederiksen J.
    Mult Scler; 2012 Jan 27; 18(1):72-81. PubMed ID: 21921071
    [Abstract] [Full Text] [Related]

  • 9. [High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome].
    Lüke C, Dohmen C, Dietlein TS, Brunner R, Lüke M, Krieglstein GK.
    Klin Monbl Augenheilkd; 2007 Dec 27; 224(12):932-4. PubMed ID: 18260057
    [Abstract] [Full Text] [Related]

  • 10. Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome.
    Kupersmith MJ, Gal RL, Beck RW, Xing D, Miller N, Optic Neuritis Study Group.
    Neurology; 2007 Aug 07; 69(6):508-14. PubMed ID: 17679669
    [Abstract] [Full Text] [Related]

  • 11. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis.
    Kolbe S, Chapman C, Nguyen T, Bajraszewski C, Johnston L, Kean M, Mitchell P, Paine M, Butzkueven H, Kilpatrick T, Egan G.
    Neuroimage; 2009 Apr 15; 45(3):679-86. PubMed ID: 19162205
    [Abstract] [Full Text] [Related]

  • 12. Color vision defect type and spatial vision in the optic neuritis treatment trial.
    Schneck ME, Haegerstrom-Portnoy G.
    Invest Ophthalmol Vis Sci; 1997 Oct 15; 38(11):2278-89. PubMed ID: 9344351
    [Abstract] [Full Text] [Related]

  • 13. Early factors associated with axonal loss after optic neuritis.
    Henderson AP, Altmann DR, Trip SA, Miszkiel KA, Schlottmann PG, Jones SJ, Garway-Heath DF, Plant GT, Miller DH.
    Ann Neurol; 2011 Dec 15; 70(6):955-63. PubMed ID: 22190367
    [Abstract] [Full Text] [Related]

  • 14. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D, Przuntek H, Sailer M, Bethke F, Koehler J, König N, Heesen C, Späth P, Andresen I.
    Mult Scler; 2007 Nov 15; 13(9):1107-17. PubMed ID: 17623736
    [Abstract] [Full Text] [Related]

  • 15. Follow-up studies on pattern reversal visually evoked cortical potentials in a 2-year-old child with optic neuritis.
    Sato K, Adachi-Usami E, Mizota A.
    J Neuroophthalmol; 1998 Mar 15; 18(1):21-4. PubMed ID: 9532534
    [Abstract] [Full Text] [Related]

  • 16. Optic neuritis: correlation of pain and magnetic resonance imaging.
    Fazzone HE, Lefton DR, Kupersmith MJ.
    Ophthalmology; 2003 Aug 15; 110(8):1646-9. PubMed ID: 12917187
    [Abstract] [Full Text] [Related]

  • 17. [Acute optic neuritis: clinical and MRI prognostic factors. Study of fifty patients].
    Deschamps R, Gout O, Fontaine B, Rigolet MH, Cabanis EA, Lyon-Caen O, Tourbah A.
    Rev Neurol (Paris); 2002 Apr 15; 158(4):446-52. PubMed ID: 11984487
    [Abstract] [Full Text] [Related]

  • 18. [Short-term effect of megadose steroid therapy in optic neuritis].
    Gerling J, Kommerell G.
    Klin Monbl Augenheilkd; 1992 Dec 15; 201(6):375-80. PubMed ID: 1287359
    [Abstract] [Full Text] [Related]

  • 19. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH.
    N Engl J Med; 1993 Dec 09; 329(24):1764-9. PubMed ID: 8232485
    [Abstract] [Full Text] [Related]

  • 20. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
    Sami N, Letko E, Androudi S, Daoud Y, Foster CS, Ahmed AR.
    Ophthalmology; 2004 Jul 09; 111(7):1380-2. PubMed ID: 15234140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.